NCI-H82 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF2412
Target Cell Organism: Human
Target Cell Alternative Name: H82
Target Cell Name: NCI-H82
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NCI-H82-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H82
Target Cell Organism
Human
Target Cell Background
The NCI-H82 cell line was derived by A.F. Gazdar and associates in 1978 from the pleural fluid of a patient with small cell cancer of the lung. The NCI-H82 cell line was derived by A.F. Gazdar and associates in 1978.
Target Cell Alternative Name
H82
Related Diseases
Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry